1. Home
  2. DGX

as 12-11-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Founded: 1967 Country:
United States
United States
Employees: N/A City: SECAUCUS
Market Cap: 17.5B IPO Year: 1996
Target Price: $166.15 AVG Volume (30 days): 869.3K
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield:
1.93%
Dividend Payout Frequency: Quarterly
EPS: 7.44 EPS Growth: 11.56
52 Week Low/High: $123.04 - $165.32 Next Earning Date: 01-30-2025
Revenue: $9,539,000,000 Revenue Growth: 2.60%
Revenue Growth (this year): 7.33% Revenue Growth (next year): 8.70%

DGX Daily Stock ML Predictions

Stock Insider Trading Activity of Quest Diagnostics Incorporated (DGX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
PREVOZNIK MICHAEL E DGX SVP & General Counsel Nov 29 '24 Sell $162.70 35,146 $5,731,301.51 38,478
DEPPE MICHAEL J DGX SVP, Corp. Controller & CAO Nov 6 '24 Sell $153.82 18,755 $2,889,122.88 45,061
KUPPUSAMY KARTHIK DGX SVP, Clinical Solutions Oct 28 '24 Sell $156.92 1,775 $278,525.19 9,734

Share on Social Networks: